Michael Plötz
Impact in
- Toxicology top 10%
-
- Cell death mechanisms and regulation
- Melanoma and MAPK Pathways
- Pluripotent Stem Cells Research
- Mitochondrial Function and Pathology
- Histone Deacetylase Inhibitors Research
Papers in
-
- Cell death mechanisms and regulation 10
- Pluripotent Stem Cells Research 1
-
- Cutaneous lymphoproliferative disorders research 2
- Co-authors
- Jürgen Eberle (14 shared papers)Anja Berger (5 shared papers)Amir M. Hossini (2 shared papers)Nadya Al‐Yacoub (2 shared papers)Frank Braun (2 shared papers)Markus Möbs (2 shared papers)Wolfram Sterry (2 shared papers)Bernhard F. Gillissen (2 shared papers)
In The Last Decade
Michael Plötz
17 papers receiving 526 citations
Peers
Comparison fields: 5 of 65
- Toxicology 27
- Molecular Biology 308
- Dermatology 31
- Oncology 43
- Cancer Research 20
Countries citing papers authored by Michael Plötz
This map shows the geographic impact of Michael Plötz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Plötz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Plötz more than expected).
Fields of papers citing papers by Michael Plötz
This network shows the impact of papers produced by Michael Plötz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Plötz. The network helps show where Michael Plötz may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Plötz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 78 | |
| 2 | 2009 | 53 | |
| 3 | 2012 | 52 | |
| 4 | 2012 | 52 | |
| 5 | 2010 | 42 | |
| 6 | 2009 | 39 | |
| 7 | 2011 | 38 | |
| 8 | 2013 | 34 | |
| 9 | 2013 | 29 | |
| 10 | 2013 | 24 | |
| 11 | 2013 | 21 | |
| 12 | 2013 | 17 | |
| 13 | 2015 | 17 | |
| 14 | 2014 | 14 | |
| 15 | 2015 | 11 | |
| 16 | 1991 | 6 | |
| 17 | 1990 | 3 |
About Michael Plötz
Michael Plötz is a scholar working on Molecular Biology, Dermatology, Toxicology, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 530 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (10 papers), Cutaneous lymphoproliferative disorders research (2 papers), Pluripotent Stem Cells Research (1 paper), Synthesis and biological activity (1 paper), Viral Infections and Immunology Research (1 paper), Carbohydrate Chemistry and Synthesis (1 paper), Organ Transplantation Techniques and Outcomes (1 paper) and Advanced MRI Techniques and Applications (1 paper). The work is most often cited by research in Toxicology (27 citations), Molecular Biology (308 citations), Dermatology (31 citations), Oncology (43 citations) and Cancer Research (20 citations). Michael Plötz has collaborated with scholars based in Germany, India and Pakistan. Frequent co-authors include Jürgen Eberle, Anja Berger, Amir M. Hossini, Nadya Al‐Yacoub, Frank Braun, Markus Möbs, Wolfram Sterry, Bernhard F. Gillissen, Peter T. Daniel and Aram Prokop. Their work appears in journals such as Journal of Investigative Dermatology, Biochemical Pharmacology, Cancer Letters, American Journal Of Pathology and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.